Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses following Natural Cholera Infection in Bangladesh
Date
2012
Author(s)
Leung, Daniel
Rahman, Mohammad Arif
Mohasin, M.
Patel, Sweta
Aktar, Amena
Khanam, Farhana
Uddin, Taher
Riyadh, M. Asrafuzzaman
Saha, Amit
Alam, Mohammad Murshid
Chowdhury, Fahima
Khan, Ashraful Islam
Charles, Richelle
LaRocque, Regina
Harris, Jason
Calderwood, Stephen
Qadri, Firdausi
Ryan, Edward
Publisher
American Society for Microbiology
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Leung, Daniel T., Mohammad Arif Rahman, M. Mohasin, Sweta M. Patel, Amena Aktar, Farhana Khanam, Taher Uddin, et al. 2012. “Memory B Cell and Other Immune Responses in Children Receiving Two Doses of an Oral Killed Cholera Vaccine Compared to Responses Following Natural Cholera Infection in Bangladesh.” Clinical and Vaccine Immunology 19 (8): 1337–1337. https://doi.org/10.1128/CVI.00299-12.
Abstract
Current oral cholera vaccines induce lower protective efficacy and shorter duration of protection against cholera than wild-type infection provides, and this difference is most pronounced in young children. Despite this, there are limited data comparing immune responses in children following wild-type disease versus vaccination, especially with regard to memory responses associated with long-term immunity. Here, we report a comparison of immune responses in young children (2 to 5 years of age; n = 20) and older children (6 to 17 years of age; n = 20) given two doses of an oral killed cholera vaccine containing recombinant cholera toxin B subunit (CtxB) 14 days apart and compare these responses to those induced in similarly aged children recovering from infection with Vibrio cholerae O1 Ogawa in Bangladesh. We found that the two vaccine groups had comparable vibriocidal and lipopolysaccharide (LPS)-specific plasma antibody responses. Vaccinees developed lower levels of IgG memory B cell (MBC) responses against CtxB but no significant MBC responses against LPS. In contrast, children recovering from natural cholera infection developed prominent LPS IgG and IgA MBC responses, as well as CtxB IgG MBC responses. Plasma LPS IgG, IgA, and IgM responses, as well as vibriocidal responses, were also significantly higher in children following disease than after vaccination. Our findings suggest that acute and memory immune responses following oral cholera vaccination in children are significantly lower than those observed following wild-type disease, especially responses targeting LPS. These findings may explain, in part, the lower efficacy of oral cholera vaccination in children.
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
Collection